Across disease status
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
Loading...
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 1.9811.476-3.166 | 8 |
| Healthy/control | 1.9741.333-3.455 | 6 |
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 1.9811.476-3.166 | 8 |
| Healthy/control | 1.9741.333-3.455 | 6 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Breast | 2.0031.466-3.122 | 11 |
| Lymphoid tissue | 1.8891.508-3.536 | 1 |
| Liver | 1.7591.224-3.323 | 2 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Healthy/control × Breast | 2.0061.367-3.337 | 4 |
| Primary cancer × Breast | 2.0031.472-3.016 | 7 |
| Primary cancer × Lymphoid tissue | 1.8891.508-3.536 | 1 |
| Healthy/control × Liver | 1.7591.224-3.323 | 2 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Primary cancer | Mean propensity | 2.377 | 8 | 2 |
| Healthy/control | Mean propensity | 2.315 | 6 | 1 |